NLRP3 and endometrial cancer: Furthermore, our investigation revealed that high expression of NLRP3, the initiator of the canonical pyroptotic pathway responsible for activating caspase-1, was linked to adverse RFS, specifically in advanced endometrial cancer, although not across all stages of endometrial cancer.